RESEARCH RESULT Pharmacology and Clinical Pharmacology

Titel Veröffentlichungsdatum Sprache Zitate
STUDYING DOSE-DEPENDENT ENDOTHELIO- AND CARDIOPROTECTIVE ACTIVITY OF SELECTIVE ARGINASE II INHIBITOR IN HYPERHOMOCYSTEINE-INDUCED ENDOTHELIAL DYSFUNCTION2016/01/013
USE OF L-ARGININE IMMOBILISED ON ACTIVATED CARBON FOR PHARMACOLOGICAL CORRECTION OF ENDOTHELIAL DISFUNCTION2016/01/013
CORRECTION OF ISCHEMIC DAMAGE TO THE RETINA ON APPLICATION OF PHARMACOLOGICAL PRECONDITIONING OF RECOMBINANT ERYTHROPOIETIN2016/01/013
PHARMACOLOGICAL CORRECTION OF L-NAME-INDUCED OXIDE DEFICIENCY WITH DERIVATIVES OF 3-(2,2,2- TRIMETHYLHYDRAZINIUM) PROPIONATE2016/01/012
PHARMACOLOGICAL PRECONDITIONING BY RECOMBINANT ERYTHROPOIETIN AS THE POSSIBILITY OF INCREASING THE STABILITY OF TISSUE OF THE RETINA TO REPERFUSION ISCHEMIA IN EXPERIMENT2016/01/012
DEVELOPMENT AND VALIDATION OF METHODS OF QUANTITATIVE DETERMINATION OF THE NEW ANTIDIABETIC DRUG IN THE BLOOD PLASMA OF RATS BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY WITH MASS SPECTROMETRIC DETECTION2016/01/012
PHARMACOLOGICAL EFFICIENCY OF STATINS AND L-NORVALIN AT AN ENDOTOXIN-INDUCED ENDOTHELIAL DYSFUNCTION2016/01/012
APPROACHES TO ANTIBIOTIC THERAPY IN PATIENTS WITH CALCULOUS PYELONEPHRITIS, UNDERGOING IN-PATIENT TREATMENT IN THE DEPARTMENT OF UROLOGY2017/01/011
STUDY OF THE INFLUENCE OF L-NORVALINE, ROSUVASTATIN AND THEIR COMBINATION ON THE LEVEL OF MICROCIRCULATION IN BONE TISSUE IN EXPERIMENTAL OSTEOPOROSIS AND FRACTURES ON ITS BACKGROUND2016/01/011
MOLECULAR SCREENING OF PROSPECTIVE CANDIDATES FOR TRPA1 ION CHANNEL SELECTIVE ANTAGONISTS2016/01/011
CHELATE COMPLEXES OF MALIC OR CITRIC ACIDS WITH IRON, MANGANESE AND ZINC AS A BIOLOGICALLY ACTIVE SUPPLEMENT FOR BROILER CHICKEN DIET2016/01/011
POSSIBLE WAYS OF PHARMACOLOGICAL CORRECTION OF ISCHEMIC DAMAGE TO THE LIVER WITH THE AGONIST OF PERIPHERAL IMIDAZOLINE RECEPTORS C70702017/01/011
METABOLIC CARDIOPROTECTION: NEW CONCEPTS IN IMPLEMENTATION OF CARDIOPROTECTIVE EFFECTS OF MELDONIUM2016/01/011
PRECLINICAL STUDY OF PHARMACOLOGICAL ACTIVITY OF ENTEROSORBENTE ON THE BASIS OF MONTMORILLONITEPRECLINICAL STUDY OF PHARMACOLOGICAL ACTIVITY OF ENTEROSORBENTE ON THE BASIS OF MONTMORILLONITE2017/01/011
RESEARCH OF WOUND HEALING EFFECT OF PHYTOMINERALSORBENT ON THE BASIS OF MONTMORILLONITE2017/01/011
METHOD OF CORRECTION OF ENDOTHELIAL DYSFUNCTION WITH COMBINATION OF ADEMETIONINE AND TAURINE2016/01/011
MELATONIN ATTENUATES THE STRESS-INDUCED DISORDERS IN PARODONTIUM AND LIVER2016/01/011
EXPERIMENTAL JUSTIFICATION OF NEW WAY OF PHARMACOLOGICAL CORRECTION FOR CONTACT FROSTBITE USING DSLET OPIOID PEPTIDE AND SEROTONIN ADIPINATE TO ENHANCE SURGYCAL TREATMENT2016/01/011
PHARMACOLOGICAL MANAGEMENT OF IMMUNE AND OXIDATIVE DISTURBANCES IN PATIENTS WITH ENCEPHALOPATHY ON THE BACKGROUND OF HYPERTENSION2016/01/01
A METHOD FOR PRODUCTION OF PHYTOMINERALSORBENT, PHYSICAL AND CHEMICAL PROPERTIES OF IT, EFFECT ON THE LIVING SYSTEMS AND THE QUALITY OF THE LIVESTOCK INDUSTRY PRODUCTS2016/01/01
THE INFLUENCE OF ELECTROLYTES OF THE IONS AND THE INHIBITOR ON THE ACTIVITY OF TOTAL ATPASE OF ERYTHROCYTES OF BROILER CHICKENS2016/01/01
EXPERIMENTAL SUBSTANTIATION EFFICIENCY OF APPLICATION OF THE AMARANTH SEEDS OIL AT COMPLICATIONS INVOKED BY ISONIAZID2016/01/01
DIABETIC FOOT SYNDROME: IMPORTANCE OF MICROBIOLOGICAL MONITORING AND ANTIMICROBIAL PENETRATION OF CHEMOTHERAPEUTIC AGENTS INTO THE SOFT TISSUE LOWER LIMB IN DETERMINING THE TREATMENT2016/01/01
PHARMACOKINETIC STUDIES DERIVED INDOLE SS-68 WITH ANTIARRHYTHMIC AND ANTIANGINAL PROPERTIES2016/01/01
INFLUENCE OF THE ENTEROSORBENT ON QUALITY OF EGGS2016/01/01
CARDIOVASCULAR EFFECTS OF AN ARGINASE II SELECTIVE INHIBITOR2016/01/01
THE ETIOLOGICAL STRUCTURE OF MASS DISEASES WITH YOUNG GASTRO AND RESPIRATORY SYNDROME2016/01/01
COMPREHENSIVE EVALUATION OF COMBINED PHARMACOTHERAPY OF CARDIAC PATHOLOGY CONSIDERING EXOGENOUS AND PHARMACOGENETIC FACTORS2016/01/01
ANTICHOLINERGIC ACTIVITY AND PHARMACOKINETIC PARAMETERS OF AGENT SS-68 WITH PROPERTIES OF CLASS III ANTIARRHYTHMIC DRUGS2016/01/01
THE POSSIBILITY OF ADMINISTRATION OF GLUTAMATE RECEPTORS ANTAGONISTS IN THE TREATMENT OF PARKINSON'S DISEASE2016/01/01